Progyny (PGNY) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Progyny, Inc. Announces Second Quarter 2021 Results
August 5, 2021 4:06 PM EDTReports Record Second Quarter Revenue of $128.7 Million, Reflecting 99% Growth
Achieving Record Sales Momentum Demand Among Prospective Accounts Returns to Pre-COVID Levels
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three-month period ended June 30, 2021 (the second quarter of 2021) as compared to the three-month period ended June 30, 2020 (the second quarter of 2020 or the prior year period).
Progyny had a solid second quarter, with our strong... More
